[HTML][HTML] Cardiovascular safety of psychedelic medicine: current status and future directions

A Wsół - Pharmacological Reports, 2023 - Springer
Psychedelics are powerful psychoactive substances that alter perception and mood
processes. Their effectiveness in the treatment of psychiatric diseases was known before …

Safety and risk assessment of psychedelic psychotherapy: a meta-analysis and systematic review

B Romeo, E Kervadec, B Fauvel, L Strika-Bruneau… - Psychiatry …, 2024 - Elsevier
Psychotherapies assisted by psychedelic substances have shown promising results in the
treatment of psychiatric disorders. The aim of this systematic review and meta-analysis was …

Association between lifetime classic psychedelic use and hypertension in the past year

O Simonsson, PS Hendricks, R Carhart-Harris… - …, 2021 - Am Heart Assoc
Using data from the National Survey on Drug Use and Health (2005–2014), weighted to be
representative of the US adult population, the present study investigated the association …

[HTML][HTML] Associations between lifetime classic psychedelic use and cardiometabolic diseases

O Simonsson, W Osika, R Carhart-Harris… - Scientific reports, 2021 - nature.com
The objective of the current study was to investigate the associations between lifetime
classic psychedelic use and cardiometabolic diseases. Using data from the National Survey …

Psychedelics as medicines: an emerging new paradigm

DE Nichols, MW Johnson… - Clinical Pharmacology & …, 2017 - Wiley Online Library
Scientific interest in serotonergic psychedelics (eg, psilocybin and LSD; 5‐HT2A receptor
agonists) has dramatically increased within the last decade. Clinical studies administering …

Associations between lifetime classic psychedelic use and markers of physical health

O Simonsson, JD Sexton… - Journal of …, 2021 - journals.sagepub.com
Background: In recent years, there has been significant research on the mental health
effects of classic psychedelic use, but there is very little evidence on how classic …

Assessing the risk–benefit profile of classical psychedelics: A clinical review of second-wave psychedelic research

D Bender, DJ Hellerstein - Psychopharmacology, 2022 - Springer
Rationale A broad reassessment of the potential benefits of psychedelic drugs has led to the
initiation of multiple major clinical trials in an effort to advance their status to become FDA …

Using psychedelics in clinical practice: Comparing therapeutic uses and potential harms

R Tariq - Current Reviews in Clinical and Experimental …, 2023 - ingentaconnect.com
Psychedelics might be the oldest psychoactive agents known to be used for inducing
religious or mystical experiences. Their strong psychoactive effect was discovered …

[HTML][HTML] Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders

H Lowe, N Toyang, B Steele, J Grant, A Ali, L Gordon… - Molecules, 2022 - mdpi.com
The word “psychedelic”(psyche (ie, the mind or soul) and delos (ie, to show)) has Greek
origin and was first coined by psychiatrist Humphry Osmond in 1956, who had been …

[HTML][HTML] Psychedelics

B Kelmendi, AP Kaye, C Pittenger, AC Kwan - Current Biology, 2022 - cell.com
Psychedelics are compounds that alter consciousness by acting on serotonin receptors in
the brain. The term 'psychedelic', from the Greek for mind manifesting, refers to the drugs' …